‘The bottom line is that mammography avert avert deaths from breast cancer, and we can make even more progress in the fight against the disease if more women age 40 and older an annual mammogram.
The Phase 2 study was conducted at the National Cancer Institute conducted in the U.S. And included four cohorts enrolling patients with liver disease and cancer and metastatic neuroendocrine, eye or cutaneous melanoma and colorectal cancer origins. ‘s primary objectives, the response rate and duration of response to intrahepatic infusion of melphalan was determined with subsequent venous hemofiltration. Secondary objective measures included hepatic PFS, overall survival, safety and tolerability. Top-line results from the study of hepatobiliary cohort were announced August 2011, and from the metastatic colorectal cohort on 1 September 2011. Continue reading